Bristol-Myers Squibb Company
DE ˙ XTRA ˙ US1101221083
47,44 € ↑0,88 (1,88%)
2026-06-03
DEL PRIS
SecurityDE:BRM / Bristol-Myers Squibb Company
InstitutionCheviot Value Management, LLC
Latest Disclosed Ownership2,125 shares
Latest Disclosed Value $ 128,881
Cheviot Value Management, LLC ownership in BRM / Bristol-Myers Squibb Company

On May 12, 2026 - Cheviot Value Management, LLC filed a 13F-HR form disclosing ownership of 2,125 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $111,392 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 3, 2026 disclosing 2,125 shares of Bristol-Myers Squibb Company. This represents a change in shares of 0.00% during the quarter. The current value of the position is $100,799 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F BRISTOL-MYERS SQUIBB CO COM Stock 110122108 2,125 0 0.00 129 10.34 0.0129
2026-02-03 2025-12-31 13F BRISTOL-MYERS SQUIBB CO COM Stock 110122108 2,125 0 0.00 116 28.89 0.0114
2025-10-31 2025-09-30 13F BRISTOL-MYERS SQUIBB CO COM Stock 110122108 2,125 -2,000 -48.48 91 -52.38 0.0097
2025-08-13 2025-06-30 13F BRISTOL-MYERS SQUIBB CO COM Stock 110122108 4,125 0 0.00 190 -8.25 0.0217
2025-05-09 2025-03-31 13F BRISTOL-MYERS SQUIBB CO COM Stock 110122108 4,125 4,125 206 0.0254
2024-02-14 2023-12-31 13F Bristol-Myers Squibb COM 110122108 0 -6,142 -100.00 0 -100.00
2023-11-07 2023-09-30 13F Bristol-Myers Squibb COM 110122108 6,142 -340 -5.25 356 -14.01 0.0789
2023-11-07 2023-06-30 13F Bristol-Myers Squibb COM 110122108 6,482 -250 -3.71 415 -11.16 0.0903
2023-05-15 2023-03-31 13F Bristol-Myers Squibb COM 110122108 6,732 -26 -0.38 467 -4.12 0.1122
2023-02-13 2022-12-31 13F Bristol-Myers Squibb COM 110122108 6,758 0 0.00 486 1.25 0.1196
2022-11-14 2022-09-30 13F Bristol-Myers Squibb COM 110122108 6,758 0 0.00 480 -7.69 0.1312
2022-08-03 2022-06-30 13F Bristol-Myers Squibb COM 110122108 6,758 0 0.00 520 5.26 0.1297
2022-05-11 2022-03-31 13F Bristol-Myers Squibb COM 110122108 6,758 0 0.00 494 17.34 0.1046
2022-02-14 2021-12-31 13F Bristol-Myers Squibb COM 110122108 6,758 0 0.00 421 5.25 0.0987
2021-11-12 2021-09-30 13F Bristol-Myers Squibb COM 110122108 6,758 0 0.00 400 -11.50 0.1026
2021-08-16 2021-06-30 13F Bristol-Myers Squibb COM 110122108 6,758 0 0.00 452 5.85 0.1110
2021-05-14 2021-03-31 13F Bristol-Myers Squibb COM 110122108 6,758 3,300 95.43 427 99.53 0.1187
2021-02-12 2020-12-31 13F Bristol-Myers Squibb COM 110122108 3,458 0 0.00 214 2.88 0.0646
2020-11-12 2020-09-30 13F Bristol-Myers Squibb COM 110122108 3,458 -224 -6.08 208 -4.15 0.0721
2020-08-17 2020-06-30 13F Bristol-Myers Squibb COM 110122108 3,682 0 0.00 217 5.85 0.0847
2020-05-13 2020-03-31 13F Bristol-Myers Squibb COM 110122108 3,682 -300 -7.53 205 -19.92 0.0935
2020-02-12 2019-12-31 13F Bristol-Myers Squibb COM 110122108 3,982 0 0.00 256 26.73 0.0986
2019-11-15 2019-09-30 13F Bristol-Myers Squibb COM 110122108 3,982 3,982 202 0.0861
2019-05-14 2019-03-31 13F Bristol-Myers Squibb COM 110122108 0 -4,057 -100.00 0 -100.00
2019-02-14 2018-12-31 13F Bristol-Myers Squibb COM 110122108 4,057 465 12.95 211 -5.38 0.1099
2018-11-13 2018-09-30 13F Bristol-Myers Squibb COM 110122108 3,592 3,592 223 0.1047
2018-08-10 2018-06-30 13F Bristol-Myers Squibb COM 110122108 0 -3,592 -100.00 0 -100.00
2018-05-11 2018-03-31 13F Bristol-Myers Squibb COM 110122108 3,592 -516 -12.56 227 -9.92 0.1181
2018-02-13 2017-12-31 13F Bristol-Myers Squibb COM 110122108 4,108 741 22.01 252 17.21 0.1305
2017-11-14 2017-09-30 13F Bristol-Myers Squibb COM 110122108 3,367 -402 -10.67 215 2.38 0.1169
2017-08-11 2017-06-30 13F Bristol-Myers Squibb COM 110122108 3,769 3,769 210 0.1224
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.